Roger Tatoud

2.2k total citations · 1 hit paper
35 papers, 1.7k citations indexed

About

Roger Tatoud is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Roger Tatoud has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Virology and 8 papers in Infectious Diseases. Recurrent topics in Roger Tatoud's work include HIV Research and Treatment (9 papers), Metabolomics and Mass Spectrometry Studies (6 papers) and HIV/AIDS Research and Interventions (5 papers). Roger Tatoud is often cited by papers focused on HIV Research and Treatment (9 papers), Metabolomics and Mass Spectrometry Studies (6 papers) and HIV/AIDS Research and Interventions (5 papers). Roger Tatoud collaborates with scholars based in United Kingdom, France and United States. Roger Tatoud's co-authors include Christine Blancher, Ayo A. Toye, Jane Fearnside, Jeremy K. Nicholson, Marc‐Emmanuel Dumas, Elaine Holmes, Richard H. Barton, Olivier Cloarec, Dominique Gauguier and Alice Rothwell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Roger Tatoud

34 papers receiving 1.7k citations

Hit Papers

Metabolic profiling reveals a contribution of gut microbi... 2006 2026 2012 2019 2006 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Tatoud United Kingdom 15 1.1k 508 393 232 154 35 1.7k
S.C. Mitchell United Kingdom 13 942 0.8× 431 0.8× 293 0.7× 156 0.7× 114 0.7× 27 1.5k
Sabrina Krautbauer Germany 22 836 0.7× 489 1.0× 651 1.7× 141 0.6× 141 0.9× 76 1.7k
Johan Renes Netherlands 23 717 0.6× 489 1.0× 421 1.1× 498 2.1× 56 0.4× 43 1.9k
Karen R. Jonscher United States 22 1.1k 1.0× 441 0.9× 379 1.0× 106 0.5× 126 0.8× 36 2.4k
Nicole de Wit Netherlands 19 817 0.7× 464 0.9× 256 0.7× 137 0.6× 170 1.1× 41 1.4k
Decherd Stump United States 24 1.2k 1.0× 577 1.1× 558 1.4× 198 0.9× 149 1.0× 41 2.2k
Jeng‐Jer Shieh Taiwan 28 857 0.8× 302 0.6× 416 1.1× 219 0.9× 151 1.0× 71 2.0k
Sylvère Durand France 22 1.3k 1.2× 460 0.9× 461 1.2× 240 1.0× 54 0.4× 50 2.2k
Landon Wilson United States 26 879 0.8× 329 0.6× 171 0.4× 93 0.4× 123 0.8× 84 2.1k
Jing Guan China 25 817 0.7× 245 0.5× 321 0.8× 149 0.6× 146 0.9× 119 2.0k

Countries citing papers authored by Roger Tatoud

Since Specialization
Citations

This map shows the geographic impact of Roger Tatoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Tatoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Tatoud more than expected).

Fields of papers citing papers by Roger Tatoud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Tatoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Tatoud. The network helps show where Roger Tatoud may publish in the future.

Co-authorship network of co-authors of Roger Tatoud

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Tatoud. A scholar is included among the top collaborators of Roger Tatoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Tatoud. Roger Tatoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tatoud, Roger, R. Brad Jones, Krista L. Dong, et al.. (2024). Advancing HIV cure research in low- and middle-income countries requires empowerment of the next generation of scientists. Journal of Virus Eradication. 10(1). 100364–100364.
3.
Prudden, H, Roger Tatoud, Robin J. Shattock, et al.. (2023). Experimental Medicine for HIV Vaccine Research and Development. Vaccines. 11(5). 970–970. 7 indexed citations
4.
Prudden, H, Roger Tatoud, Holly Janes, et al.. (2023). Perspectives on Design Approaches for HIV Prevention Efficacy Trials. AIDS Research and Human Retroviruses. 40(5). 301–307. 1 indexed citations
5.
Herath, S., Stefano Colloca, Steven Patterson, et al.. (2016). Strain-dependent and distinctive T-cell responses to HIV antigens following immunisation of mice with differing chimpanzee adenovirus vaccine vectors. Vaccine. 34(37). 4378–4385. 7 indexed citations
6.
Herath, S., Stefano Colloca, Philip Bergin, et al.. (2015). Analysis of T cell responses to chimpanzee adenovirus vectors encoding HIV gag–pol–nef antigen. Vaccine. 33(51). 7283–7289. 7 indexed citations
7.
Knudsen, Maria L., Karl Ljungberg, Roger Tatoud, et al.. (2015). Alphavirus Replicon DNA Expressing HIV Antigens Is an Excellent Prime for Boosting with Recombinant Modified Vaccinia Ankara (MVA) or with HIV gp140 Protein Antigen. PLoS ONE. 10(2). e0117042–e0117042. 23 indexed citations
8.
McKay, Paul F., Alethea Cope, Jamie F. S. Mann, et al.. (2014). Glucopyranosyl Lipid A Adjuvant Significantly Enhances HIV Specific T and B Cell Responses Elicited by a DNA-MVA-Protein Vaccine Regimen. PLoS ONE. 9(1). e84707–e84707. 29 indexed citations
9.
10.
Fearnside, Jane, Marc‐Emmanuel Dumas, Alice Rothwell, et al.. (2008). Phylometabonomic Patterns of Adaptation to High Fat Diet Feeding in Inbred Mice. PLoS ONE. 3(2). e1668–e1668. 81 indexed citations
11.
Toye, Ayo A., Marc‐Emmanuel Dumas, Christine Blancher, et al.. (2007). Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. Diabetologia. 50(9). 1867–1879. 93 indexed citations
12.
Mackay, Alan, Jeremy Clark, Christopher J. Shepherd, et al.. (2006). A conditionally immortalized cell line model for the study of human prostatic epithelial cell differentiation. Differentiation. 75(1). 35–48. 10 indexed citations
13.
Adamson, Douglas, et al.. (2002). Diclofenac Antagonizes Peroxisome Proliferator-Activated Receptor-γ Signaling. Molecular Pharmacology. 61(1). 7–12. 68 indexed citations
14.
Sangrajrang, Suleeporn, Philippe Denoulet, Naomi Laing, et al.. (1998). Association of Estramustine Resistance in Human Prostatic Carcinoma Cells with Modified Patterns of Tubulin Expression. Biochemical Pharmacology. 55(3). 325–331. 29 indexed citations
15.
Degeorges, Armelle, Roger Tatoud, Françoise Fauvel-Lafève, et al.. (1996). Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. International Journal of Cancer. 68(2). 207–214. 81 indexed citations
16.
Tatoud, Roger, et al.. (1995). Somatostatin receptors in prostate tissues and derived cell cultures, and the in vitro growth inhibitory effect of BIM-23014 analog. Molecular and Cellular Endocrinology. 113(2). 195–204. 14 indexed citations
17.
Desgrandchamps, F., et al.. (1992). [Prostatic growth factors and benign hypertrophy of the prostate. Current knowledge and perspectives].. PubMed. 2(6). 1031–44. 3 indexed citations
18.
Desgrandchamps, François, Roger Tatoud, Olivier Cussenot, et al.. (1992). Facteurs de croissance prostatiques et hypertrophie bénigne de la pr ostate Etat des connaissances actuelles et perspectives. Progrès en Urologie. 2(6). 3 indexed citations
19.
Moyec, Laurence Le, et al.. (1992). Cell and membrane lipid analysis by proton magnetic resonance spectroscopy in five breast cancer cell lines. British Journal of Cancer. 66(4). 623–628. 31 indexed citations
20.
Eugène, Michel, et al.. (1991). [Lipid profiles of breast cancer cell lines: proton nuclear magnetic resonance spectroscopy].. PubMed. 312(1). 25–30. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026